or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    SUPN D Supernus Pharmaceuticals, Inc. -0.21
    LGND C Ligand Pharmaceuticals Incorporated 1.22
    LBPH B Longboard Pharmaceuticals, Inc. 0.88
    INCY D Incyte Corporation 0.42
    HCM B Hutchison China MediTech Limited -3.77
    HALO C Halozyme Therapeutics, Inc. -1.50
    BIIB C Biogen Idec Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    PJP A PowerShares Dynamic Pharmaceuticals 11.53
    FBT C First Trust Amex Biotech Index Fund 10.56
    IBRN D iShares Neuroscience and Healthcare ETF 9.32
    BIS F ProShares UltraShort Nasdaq Biotechnology 9.05
    PBE C PowerShares Dynamic Biotech & Genome 8.38
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare FBT to PBE Compare PJP to BIS Compare PJP to IBRN

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 LGND Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 INCY Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
        May 17 LGND Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
        May 17 LGND Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
        May 17 LGND Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 17 HCM HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
        May 16 HALO Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 LGND Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
        May 16 LGND Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
        May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 LGND Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags